| Date Filed | Type | Description |
| 07/05/2022 |
SC 13G/A
| Vivo Capital IX, LLC reports a 0% stake in Sierra Oncology, Inc. |
| 02/11/2022 |
SC 13G/A
| Vivo Capital IX, LLC reports a 1.8% stake in Larimar Therapeutics, Inc. |
| 02/11/2022 |
SC 13G/A
| Vivo Capital IX, LLC reports a 7.8% stake in Mereo BioPharma Group plc |
| 02/11/2022 |
SC 13G/A
| Vivo Capital IX, LLC reports a 4.5% stake in IVERIC bio, Inc. |
| 02/11/2022 |
SC 13G/A
| Vivo Capital IX, LLC reports a 1.4% stake in ESSA Pharma Inc. |
| 02/11/2022 |
SC 13G/A
| Vivo Capital IX, LLC reports a 14.7% stake in Sierra Oncology, Inc. |
| 02/11/2022 |
SC 13G/A
| Vivo Capital IX, LLC reports a 14.4% stake in Tarsus Pharmaceuticals, Inc. |
| 11/12/2021 |
SC 13G
| Vivo Capital IX, LLC reports a 10.5% stake in IO Biotech, Inc. |
| 11/05/2021 |
SC 13G/A
| Vivo Capital IX, LLC reports a 14.8% stake in Sierra Oncology, Inc. |
| 07/23/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 04/01/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 11/06/2020 |
SC 13G
| Vivo Capital IX, LLC reports a 4.4% stake in ESSA Pharma Inc. |
| 10/28/2020 |
SC 13G
| Vivo Capital IX, LLC reports a 16.2% stake in Tarsus Pharmaceuticals, Inc. |
| 07/29/2020 |
SC 13G
| Vivo Capital IX, LLC reports a 11.1% stake in ALX Oncology Holdings Inc. |
| 07/10/2020 |
SC 13G/A
| Vivo Capital IX, LLC reports a 9% stake in Mereo BioPharma Group plc |
| 06/30/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 06/26/2020 |
SC 13G/A
| Vivo Capital IX, LLC reports a 1.6% stake in Selecta Biosciences, Inc. |
| 06/26/2020 |
SC 13G
| Vivo Capital IX, LLC reports a 5.8% stake in IVERIC bio, Inc. |
| 06/12/2020 |
SC 13G
| Vivo Capital IX, LLC reports a 6.6% stake in Mereo BioPharma Group plc |
| 06/11/2020 |
SC 13G
| Vivo Capital IX, LLC reports a 5.2% stake in Aduro Biotech, Inc. |
| 06/11/2020 |
SC 13G
| Vivo Capital IX, LLC reports a 4.3% stake in Larimar Therapeutics, Inc. |
| 02/13/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/03/2020 |
SC 13G
| Vivo Capital IX, LLC reports a 4.9% stake in Trillium Therapeutics, Inc. |
| 12/30/2019 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |